Poland· PL-100446135
Trixeo Aerosphere
A formoterol, glycopyrronium bromid und budesonid product containing formoteroli fumaras dihydricus + glycopyrronium + budesonidum, registered in Poland by AstraZeneca AB. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Formoterol, glycopyrronium bromid und budesonid is registered in 11 of 19 countries.
Countries holding a registration under ATC R03AL11 (formoterol, glycopyrronium bromid und budesonid), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Formoterol, glycopyrronium bromid und budesonid · ATC R03AL11
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Formoteroli fumaras dihydricus + Glycopyrronium + Budesonidum
- Manufacturer
- AstraZeneca AB
- Country
- Poland (PL)
- ATC code
- R03AL11
- ATC class
- Formoterol, Glycopyrronium bromid und Budesonid
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
1 priced- gtin05000456068611
- gtin050004560715051 poj. 120 dawekPLN 247.27
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Formoterol, glycopyrronium bromid und budesonid in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandTrixeo Aerosphere 5/7.2/160 μg, Druckgasinhalation, SuspensionAstraZeneca AG
- IcelandRiltrava AerosphereAstraZeneca AB
- NetherlandsRiltrava Aerosphere 5 microgram/7,2 microgram/160 microgram, aerosol, suspensie, suspensieAstraZeneca AB
- CanadaBREZTRI AEROSPHEREASTRAZENECA CANADA INC
- SpainTRIXEO AEROSPHERE 5 microgramos/7,2 microgramos/160 microgramos SUSPENSION PARA INHALACION EN ENVASE A PRESIONAstrazeneca Ab
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4ea33192-9fb3-412f-9414-0d166529492c GET /v1/drugs/4ea33192-9fb3-412f-9414-0d166529492c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Aerozol inhalacyjny, zawiesina",
"source": "urpl",
"strength": "5 mcg + 7,2 mcg + 160 mcg",
"packaging": "05000456068611 ¦ Rp ¦ Skasowane ¦ EU/1/20/1498/002 ¦ 138864\n1 poj. 120 dawek\nRp ¦ Skasowane ¦ EU/1/20/1498/001 ¦ 138865\n1 poj. 56 dawek\nRp ¦ EU/1/20/1498/003 ¦ 138866\n3 poj. 120 dawek (opakowanie zbiorcze)\n05000456071505 ¦ Rp ¦ EU/1/20/1498/002 ¦ 144875\n1 poj. 120 dawek",
"substance": "Formoteroli fumaras dihydricus 5 mcg + Glycopyrronium 9 mcg + Budesonidum 160 mcg",
"common_name": "Formoteroli fumaras dihydricus + Glycopyrronium + Budesonidum",
"pl_product_id": "100446135",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about formoterol, glycopyrronium bromid und budesonid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.